Prevalence and risk factors of multidrug-resistant Pseudomonas aeruginosa pneumonia in intensive care unit

Hai LIN,Yuetian YU,Cheng ZHU,Chunyan LIU,Yanping ZHU,Min LI
DOI: https://doi.org/10.3978/j.issn.2095-6959.2017.10.010
2017-01-01
Abstract:Objective:To investigate the prevalence and risk factors associated with multidrug-resistant Pseudomonas aeruginosa (MDR-Pa) pneumonia among intensive care unit (ICU) patients.Methods:A total of 362 patients with pseudomonas aeruginosa pneumonia from 3 teaching hospitals ICU were enrolled in this retrospective case-control study.Patients with MDR-Pa pneumonia were assigned to MDR-Pa group (n=127),the others were assigned to non-MDR-Pa group (n=235).The prevalence of anti-pseudomonal antibiotic susceptibility was documented.Risk factors included comorbid conditions and prior healthcare exposure (hospitalizations,pseudomonas aeruginosa colonization/infection,mechanical ventilation,etc.) were detected and compared.Results:The anti-pseudomonal antibiotic susceptibility in ICU isolated strains was much lower than that of the CHINET.Multivariate logistic regression analysis showed that antibiotics treatment ≥24 h in preceding 90 days (OR =4.1,95%CI 1.9-6.8),hospitalization ≥48 h in preceding 90 days (OR =2.8,95%CI 1.1-5.4),residence of nursing home (OR =3.5,95%CI 2.0-6.3),pseudomonas aeruginosa colonization or infection in preceding 1 year (OR =5.2,95%CI 1.9-8.4) were the high risk factors for MDR-Pa pulmonary in ICU patients (P<0.05).Among the prior anti-pseudomonal antibiotic exposure,carbapenems (OR =8.3,95%CI 3.7-22.8),fluoroquinolones (OR =6.3,95%CI 3.2-8.2) and β-lactamase inhibitor (OR =3.2,95%CI 1.5-6.5) were also risk factors (P<0.05).Conclusion:Patients with MDR-Pa pneumonia should be thoroughly assessed for prior healthcare exposure and anti-pseudomonal antibiotic exposure.
What problem does this paper attempt to address?